Patricia C. Kienle, RPh, director of accreditation and medication safety for Cardinal Health Innovative Delivery Solutions, is urging pharmacies to begin planning to become compliant with requirements for handling hazardous drugs, specified in the United States Pharmacopeia’s draft chapter 800. More
FDA approved dinutuximab (Unituxin, United Therapeutics) as part of first-line therapy for pediatric patients with high-risk neuroblastoma, a type of cancer that most often occurs in young children. More
Isavuconazonium sulfate (Cresemba, Astellas Pharma US) has just been approved by FDA for the treatment of adults suffering from the rare but serious infections of invasive aspergillosis and invasive mucormycosis. Individuals with weakened immune systems are most prone to these infections. More